| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gingiva | 14 | 2024 | 16 | 1.750 |
Why?
|
| Periodontitis | 8 | 2024 | 62 | 1.170 |
Why?
|
| Periodontal Ligament | 10 | 2024 | 10 | 1.110 |
Why?
|
| Brain-Derived Neurotrophic Factor | 11 | 2024 | 81 | 1.060 |
Why?
|
| Gastroesophageal Reflux | 4 | 2023 | 37 | 1.040 |
Why?
|
| Mesenchymal Stem Cells | 8 | 2022 | 72 | 1.020 |
Why?
|
| Waste Management | 4 | 2010 | 7 | 0.960 |
Why?
|
| Epithelial Cells | 14 | 2024 | 434 | 0.870 |
Why?
|
| Transforming Growth Factor beta | 10 | 2024 | 216 | 0.840 |
Why?
|
| Helicobacter pylori | 2 | 2023 | 118 | 0.820 |
Why?
|
| Interleukin-8 | 9 | 2017 | 74 | 0.810 |
Why?
|
| Dyspepsia | 1 | 2023 | 6 | 0.810 |
Why?
|
| Cells, Cultured | 29 | 2022 | 1621 | 0.730 |
Why?
|
| Bone Regeneration | 7 | 2024 | 10 | 0.720 |
Why?
|
| Osteogenesis | 10 | 2022 | 57 | 0.720 |
Why?
|
| Triazines | 4 | 2013 | 25 | 0.720 |
Why?
|
| Hydrogen | 2 | 2020 | 47 | 0.650 |
Why?
|
| Aspirin | 4 | 2014 | 89 | 0.630 |
Why?
|
| Japan | 15 | 2023 | 348 | 0.620 |
Why?
|
| Lymph Nodes | 2 | 2016 | 74 | 0.590 |
Why?
|
| Osteonectin | 3 | 2004 | 10 | 0.580 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 7 | 2017 | 105 | 0.570 |
Why?
|
| Humans | 89 | 2025 | 43102 | 0.570 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 5 | 2018 | 14 | 0.550 |
Why?
|
| China | 8 | 2020 | 229 | 0.540 |
Why?
|
| Smad2 Protein | 3 | 2016 | 11 | 0.530 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2013 | 146 | 0.520 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 184 | 0.510 |
Why?
|
| Fibronectins | 3 | 2016 | 69 | 0.500 |
Why?
|
| Membrane Proteins | 4 | 2014 | 561 | 0.500 |
Why?
|
| Inflammation | 7 | 2019 | 758 | 0.490 |
Why?
|
| Amyloidosis | 1 | 2016 | 37 | 0.490 |
Why?
|
| Calcinosis | 1 | 2016 | 62 | 0.480 |
Why?
|
| Industry | 6 | 2014 | 31 | 0.470 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2016 | 57 | 0.450 |
Why?
|
| Conservation of Natural Resources | 7 | 2014 | 48 | 0.450 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2015 | 98 | 0.440 |
Why?
|
| Pancreatic Neoplasms | 5 | 2023 | 218 | 0.440 |
Why?
|
| Extracellular Matrix | 4 | 2019 | 131 | 0.430 |
Why?
|
| Environmental Monitoring | 3 | 2014 | 230 | 0.430 |
Why?
|
| Alveolar Bone Loss | 2 | 2024 | 19 | 0.430 |
Why?
|
| Simian immunodeficiency virus | 1 | 2014 | 60 | 0.430 |
Why?
|
| Dinoflagellida | 4 | 2008 | 11 | 0.420 |
Why?
|
| Dust | 1 | 2014 | 57 | 0.420 |
Why?
|
| Animals | 44 | 2024 | 16992 | 0.420 |
Why?
|
| Metals, Heavy | 1 | 2014 | 71 | 0.410 |
Why?
|
| Dental Cementum | 7 | 2024 | 7 | 0.410 |
Why?
|
| Dental Pulp | 5 | 2017 | 12 | 0.400 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2013 | 77 | 0.400 |
Why?
|
| Guideline Adherence | 2 | 2013 | 98 | 0.390 |
Why?
|
| Immunotherapy | 1 | 2014 | 144 | 0.390 |
Why?
|
| Soil Pollutants | 1 | 2014 | 105 | 0.390 |
Why?
|
| Adenocarcinoma, Mucinous | 3 | 2023 | 24 | 0.390 |
Why?
|
| Cell Differentiation | 12 | 2022 | 638 | 0.390 |
Why?
|
| Male | 39 | 2024 | 23409 | 0.390 |
Why?
|
| Epithelial Attachment | 1 | 2012 | 3 | 0.380 |
Why?
|
| Genes, bcl-2 | 1 | 2012 | 7 | 0.380 |
Why?
|
| Membrane Transport Proteins | 2 | 2025 | 100 | 0.380 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2014 | 226 | 0.380 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 51 | 0.380 |
Why?
|
| Neutrophils | 4 | 2016 | 145 | 0.370 |
Why?
|
| Peptic Ulcer | 4 | 2014 | 15 | 0.370 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 1596 | 0.370 |
Why?
|
| Apoptosis | 7 | 2016 | 1568 | 0.350 |
Why?
|
| Interleukin-6 | 5 | 2024 | 165 | 0.350 |
Why?
|
| Waste Products | 2 | 2010 | 5 | 0.350 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 161 | 0.350 |
Why?
|
| Cytokines | 6 | 2021 | 678 | 0.340 |
Why?
|
| Endoscopy, Gastrointestinal | 4 | 2023 | 23 | 0.340 |
Why?
|
| Porphyromonas gingivalis | 4 | 2024 | 40 | 0.330 |
Why?
|
| Refuse Disposal | 2 | 2009 | 17 | 0.330 |
Why?
|
| Plastics | 1 | 2010 | 14 | 0.330 |
Why?
|
| Cell Proliferation | 12 | 2024 | 1455 | 0.330 |
Why?
|
| Cadherins | 2 | 2015 | 102 | 0.330 |
Why?
|
| Cementogenesis | 2 | 2024 | 2 | 0.330 |
Why?
|
| Arthritis, Experimental | 2 | 2020 | 8 | 0.320 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 28 | 0.320 |
Why?
|
| Cyclosporine | 2 | 2021 | 36 | 0.300 |
Why?
|
| Gastric Mucosa | 4 | 2013 | 65 | 0.300 |
Why?
|
| Collagen Type I | 4 | 2018 | 35 | 0.300 |
Why?
|
| Gap Junctions | 2 | 2006 | 49 | 0.300 |
Why?
|
| Esophagitis, Peptic | 3 | 2018 | 4 | 0.300 |
Why?
|
| Bacteroidaceae Infections | 2 | 2018 | 7 | 0.300 |
Why?
|
| Pyrans | 2 | 2006 | 10 | 0.290 |
Why?
|
| Mice | 21 | 2024 | 6644 | 0.290 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2005 | 6 | 0.290 |
Why?
|
| Glycoproteins | 3 | 2024 | 125 | 0.290 |
Why?
|
| Cell Communication | 2 | 2006 | 114 | 0.280 |
Why?
|
| MAP Kinase Signaling System | 4 | 2015 | 196 | 0.280 |
Why?
|
| MicroRNAs | 3 | 2021 | 518 | 0.280 |
Why?
|
| Gingival Overgrowth | 2 | 2019 | 2 | 0.280 |
Why?
|
| Alkaline Phosphatase | 4 | 2007 | 54 | 0.280 |
Why?
|
| Periodontium | 4 | 2024 | 5 | 0.280 |
Why?
|
| Cell Membrane Permeability | 2 | 2015 | 57 | 0.270 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 1070 | 0.270 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2023 | 67 | 0.270 |
Why?
|
| Female | 32 | 2024 | 24698 | 0.270 |
Why?
|
| Phosphorylation | 10 | 2016 | 986 | 0.260 |
Why?
|
| Fibroblasts | 3 | 2024 | 281 | 0.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2024 | 384 | 0.250 |
Why?
|
| Alkenes | 1 | 2006 | 17 | 0.250 |
Why?
|
| Streptomyces | 5 | 2010 | 22 | 0.240 |
Why?
|
| Immunosuppressive Agents | 2 | 2021 | 94 | 0.240 |
Why?
|
| Gene Expression | 5 | 2016 | 701 | 0.240 |
Why?
|
| Proteus mirabilis | 1 | 2025 | 3 | 0.240 |
Why?
|
| Putrescine | 1 | 2025 | 27 | 0.240 |
Why?
|
| Osteopontin | 6 | 2024 | 46 | 0.240 |
Why?
|
| Prospective Studies | 5 | 2023 | 1600 | 0.230 |
Why?
|
| Antineoplastic Agents | 6 | 2010 | 1019 | 0.230 |
Why?
|
| Skull | 2 | 2017 | 28 | 0.230 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2005 | 1 | 0.230 |
Why?
|
| Bacterial Proteins | 2 | 2025 | 595 | 0.220 |
Why?
|
| Porifera | 3 | 2010 | 16 | 0.220 |
Why?
|
| Chemotaxis | 1 | 2005 | 68 | 0.220 |
Why?
|
| Receptor, trkB | 3 | 2014 | 20 | 0.220 |
Why?
|
| Cities | 3 | 2009 | 79 | 0.220 |
Why?
|
| Antigens, CD | 1 | 2005 | 127 | 0.220 |
Why?
|
| Aged | 16 | 2023 | 8214 | 0.210 |
Why?
|
| Growth Substances | 1 | 2004 | 16 | 0.210 |
Why?
|
| Pancreatic Ducts | 3 | 2013 | 9 | 0.210 |
Why?
|
| RNA, Messenger | 9 | 2023 | 1271 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2016 | 279 | 0.210 |
Why?
|
| Anti-Ulcer Agents | 2 | 2014 | 7 | 0.210 |
Why?
|
| Pancreatic Cyst | 1 | 2023 | 7 | 0.210 |
Why?
|
| Calcium | 3 | 2021 | 491 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2015 | 299 | 0.200 |
Why?
|
| Water Supply | 2 | 2014 | 60 | 0.200 |
Why?
|
| Tissue Engineering | 5 | 2019 | 75 | 0.200 |
Why?
|
| Hernia, Hiatal | 3 | 2018 | 7 | 0.200 |
Why?
|
| Osteoblasts | 2 | 2020 | 44 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2018 | 187 | 0.200 |
Why?
|
| DNA Replication | 1 | 2004 | 148 | 0.190 |
Why?
|
| Antifungal Agents | 4 | 2006 | 169 | 0.190 |
Why?
|
| Middle Aged | 21 | 2024 | 12222 | 0.190 |
Why?
|
| Tissue Scaffolds | 2 | 2014 | 35 | 0.190 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 3156 | 0.190 |
Why?
|
| Periodontal Diseases | 2 | 2018 | 49 | 0.190 |
Why?
|
| Diabetic Neuropathies | 1 | 2022 | 12 | 0.190 |
Why?
|
| Diabetic Angiopathies | 1 | 2022 | 26 | 0.190 |
Why?
|
| Pancreatitis | 2 | 2013 | 21 | 0.180 |
Why?
|
| Signal Transduction | 10 | 2018 | 2157 | 0.180 |
Why?
|
| Cathelicidins | 2 | 2013 | 4 | 0.180 |
Why?
|
| Regeneration | 5 | 2016 | 32 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 1869 | 0.180 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2021 | 3 | 0.180 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2016 | 57 | 0.180 |
Why?
|
| Stomach Neoplasms | 3 | 2013 | 241 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2022 | 61 | 0.180 |
Why?
|
| Cohort Studies | 2 | 2023 | 1759 | 0.170 |
Why?
|
| Retrospective Studies | 10 | 2023 | 2544 | 0.170 |
Why?
|
| Guided Tissue Regeneration, Periodontal | 2 | 2024 | 2 | 0.170 |
Why?
|
| Molar, Third | 1 | 2020 | 1 | 0.170 |
Why?
|
| Aggressive Periodontitis | 1 | 2020 | 2 | 0.160 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2020 | 9 | 0.160 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 152 | 0.160 |
Why?
|
| Esophagoscopy | 3 | 2018 | 7 | 0.160 |
Why?
|
| SOXC Transcription Factors | 1 | 2020 | 3 | 0.160 |
Why?
|
| Rats, Inbred F344 | 4 | 2018 | 258 | 0.160 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 34 | 0.160 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 18 | 0.160 |
Why?
|
| Cell Line | 8 | 2016 | 1410 | 0.160 |
Why?
|
| Mutation, Missense | 1 | 2020 | 91 | 0.160 |
Why?
|
| Myeloid Cells | 1 | 2019 | 31 | 0.150 |
Why?
|
| Adult | 16 | 2024 | 13872 | 0.150 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 32 | 0.150 |
Why?
|
| Enzyme Inhibitors | 5 | 2012 | 458 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 83 | 0.150 |
Why?
|
| Proton Pump Inhibitors | 2 | 2017 | 16 | 0.150 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 2853 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 6 | 2010 | 157 | 0.150 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2015 | 97 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2012 | 1124 | 0.150 |
Why?
|
| Porphyromonas | 1 | 2018 | 1 | 0.150 |
Why?
|
| Peptidoglycan | 2 | 2017 | 12 | 0.150 |
Why?
|
| Glycyrrhizic Acid | 1 | 2018 | 4 | 0.150 |
Why?
|
| Osseointegration | 1 | 2018 | 3 | 0.150 |
Why?
|
| Complement C5a | 1 | 2018 | 2 | 0.150 |
Why?
|
| Calcium Channel Blockers | 1 | 2019 | 55 | 0.150 |
Why?
|
| NF-kappa B | 3 | 2010 | 358 | 0.140 |
Why?
|
| Phosphoproteins | 2 | 2018 | 206 | 0.140 |
Why?
|
| Molecular Structure | 10 | 2010 | 570 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 8 | 2007 | 301 | 0.140 |
Why?
|
| Macrolides | 2 | 2010 | 14 | 0.140 |
Why?
|
| Marine Toxins | 3 | 2008 | 17 | 0.140 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2018 | 4 | 0.140 |
Why?
|
| Dogs | 4 | 2024 | 204 | 0.140 |
Why?
|
| Intestinal Mucosa | 4 | 2013 | 134 | 0.140 |
Why?
|
| Gingival Crevicular Fluid | 1 | 2018 | 2 | 0.140 |
Why?
|
| Blotting, Western | 4 | 2016 | 883 | 0.140 |
Why?
|
| Actinobacteria | 2 | 2009 | 14 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 2 | 2016 | 209 | 0.140 |
Why?
|
| Cryopreservation | 1 | 2018 | 39 | 0.140 |
Why?
|
| Barrett Esophagus | 1 | 2018 | 29 | 0.140 |
Why?
|
| Water | 1 | 2020 | 316 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 241 | 0.140 |
Why?
|
| Macaca mulatta | 2 | 2016 | 139 | 0.130 |
Why?
|
| Histamine H2 Antagonists | 2 | 2014 | 5 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 200 | 0.130 |
Why?
|
| Macrophages | 4 | 2010 | 529 | 0.130 |
Why?
|
| Rhodamines | 1 | 2017 | 22 | 0.130 |
Why?
|
| Viral Load | 2 | 2019 | 348 | 0.130 |
Why?
|
| Ligation | 1 | 2017 | 12 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2018 | 124 | 0.130 |
Why?
|
| Coculture Techniques | 4 | 2022 | 109 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 131 | 0.130 |
Why?
|
| Postoperative Complications | 3 | 2013 | 263 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 213 | 0.130 |
Why?
|
| Benzamides | 2 | 2015 | 81 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2018 | 171 | 0.130 |
Why?
|
| Plasma Cells | 1 | 2016 | 12 | 0.130 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 184 | 0.130 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 53 | 0.120 |
Why?
|
| Waste Disposal, Fluid | 2 | 2014 | 19 | 0.120 |
Why?
|
| Time Factors | 3 | 2012 | 1857 | 0.120 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2016 | 22 | 0.120 |
Why?
|
| Cell Line, Transformed | 5 | 2016 | 95 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 65 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 59 | 0.120 |
Why?
|
| Interferon-gamma | 1 | 2017 | 269 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 75 | 0.120 |
Why?
|
| Azithromycin | 1 | 2015 | 7 | 0.120 |
Why?
|
| Gastroscopy | 2 | 2013 | 9 | 0.120 |
Why?
|
| Receptors, Cell Surface | 2 | 2013 | 146 | 0.120 |
Why?
|
| Alcohol Drinking | 2 | 2018 | 609 | 0.120 |
Why?
|
| Endothelial Cells | 3 | 2016 | 329 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 73 | 0.120 |
Why?
|
| Cell Movement | 4 | 2013 | 655 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2006 | 51 | 0.110 |
Why?
|
| Parietal Bone | 1 | 2015 | 1 | 0.110 |
Why?
|
| Colonic Neoplasms | 4 | 2011 | 223 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2014 | 245 | 0.110 |
Why?
|
| Alveolar Process | 1 | 2014 | 3 | 0.110 |
Why?
|
| Famotidine | 1 | 2014 | 2 | 0.110 |
Why?
|
| Calcium Phosphates | 1 | 2014 | 15 | 0.110 |
Why?
|
| Urban Renewal | 1 | 2014 | 2 | 0.110 |
Why?
|
| Rats | 5 | 2018 | 3735 | 0.110 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2014 | 34 | 0.110 |
Why?
|
| Lung | 1 | 2018 | 492 | 0.110 |
Why?
|
| Life Style | 2 | 2018 | 334 | 0.110 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 436 | 0.110 |
Why?
|
| Immunologic Memory | 1 | 2014 | 42 | 0.110 |
Why?
|
| Environment | 3 | 2014 | 149 | 0.110 |
Why?
|
| Amphotericin B | 1 | 2014 | 25 | 0.110 |
Why?
|
| Actins | 2 | 2018 | 164 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2012 | 152 | 0.110 |
Why?
|
| Biodegradation, Environmental | 1 | 2014 | 82 | 0.110 |
Why?
|
| Bioreactors | 1 | 2014 | 30 | 0.110 |
Why?
|
| Diterpenes | 1 | 2014 | 97 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 760 | 0.100 |
Why?
|
| Risk Factors | 7 | 2020 | 3994 | 0.100 |
Why?
|
| Lactoferrin | 1 | 2013 | 9 | 0.100 |
Why?
|
| Mucin-2 | 1 | 2013 | 1 | 0.100 |
Why?
|
| Mass Spectrometry | 5 | 2006 | 280 | 0.100 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2013 | 9 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2020 | 590 | 0.100 |
Why?
|
| Gastric Stump | 1 | 2013 | 1 | 0.100 |
Why?
|
| Gastrectomy | 1 | 2013 | 13 | 0.100 |
Why?
|
| Endoscopy | 1 | 2013 | 17 | 0.100 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 27 | 0.100 |
Why?
|
| HIV Infections | 2 | 2019 | 2586 | 0.100 |
Why?
|
| Stents | 1 | 2013 | 67 | 0.100 |
Why?
|
| Actinobacillus Infections | 1 | 2013 | 4 | 0.100 |
Why?
|
| Interleukin-1 | 2 | 2004 | 39 | 0.100 |
Why?
|
| Sphincter of Oddi Dysfunction | 1 | 2012 | 1 | 0.100 |
Why?
|
| Sphincter of Oddi | 1 | 2012 | 2 | 0.100 |
Why?
|
| Manometry | 1 | 2012 | 8 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 665 | 0.100 |
Why?
|
| Intestines | 1 | 2013 | 71 | 0.100 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 719 | 0.100 |
Why?
|
| Antigens, Bacterial | 2 | 2013 | 144 | 0.100 |
Why?
|
| Soil | 1 | 2014 | 171 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 310 | 0.100 |
Why?
|
| Drug Prescriptions | 1 | 2013 | 60 | 0.090 |
Why?
|
| Models, Theoretical | 2 | 2012 | 232 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2012 | 26 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2014 | 432 | 0.090 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2012 | 5 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 138 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 223 | 0.090 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2012 | 21 | 0.090 |
Why?
|
| Virus Replication | 1 | 2014 | 318 | 0.090 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2012 | 18 | 0.090 |
Why?
|
| Lymphocyte Subsets | 1 | 2012 | 21 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2002 | 66 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2012 | 32 | 0.090 |
Why?
|
| Dissection | 1 | 2012 | 13 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1180 | 0.090 |
Why?
|
| General Surgery | 1 | 2012 | 28 | 0.090 |
Why?
|
| Homeostasis | 1 | 2013 | 192 | 0.090 |
Why?
|
| Oropharynx | 1 | 2011 | 6 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1542 | 0.090 |
Why?
|
| Pharyngitis | 1 | 2011 | 5 | 0.090 |
Why?
|
| Endoscopy, Digestive System | 1 | 2011 | 7 | 0.090 |
Why?
|
| Esophagus | 1 | 2012 | 42 | 0.090 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2011 | 11 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2012 | 61 | 0.090 |
Why?
|
| Carcinoma in Situ | 1 | 2011 | 16 | 0.090 |
Why?
|
| Spectrophotometry, Ultraviolet | 3 | 2006 | 104 | 0.090 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 4 | 2006 | 10 | 0.090 |
Why?
|
| Enzyme Activation | 3 | 2012 | 462 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2014 | 863 | 0.090 |
Why?
|
| Vitamin K 3 | 1 | 2011 | 2 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 104 | 0.080 |
Why?
|
| Hela Cells | 5 | 2011 | 376 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2016 | 108 | 0.080 |
Why?
|
| Hyaluronic Acid | 1 | 2011 | 36 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 934 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2024 | 536 | 0.080 |
Why?
|
| Arteriosclerosis | 1 | 2010 | 43 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2016 | 105 | 0.080 |
Why?
|
| Sphingosine | 1 | 2010 | 22 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 2010 | 15 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 291 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 83 | 0.080 |
Why?
|
| Environmental Pollution | 1 | 2010 | 27 | 0.080 |
Why?
|
| Carcinoma, Ductal | 1 | 2010 | 5 | 0.080 |
Why?
|
| Colonoscopy | 1 | 2011 | 122 | 0.080 |
Why?
|
| Chemokine CXCL1 | 1 | 2010 | 18 | 0.080 |
Why?
|
| Lipoxins | 1 | 2009 | 2 | 0.080 |
Why?
|
| Hemolysis | 2 | 2008 | 60 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 1 | 2009 | 44 | 0.080 |
Why?
|
| Cell Survival | 4 | 2018 | 945 | 0.080 |
Why?
|
| Epithelium | 1 | 2010 | 78 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2017 | 1604 | 0.080 |
Why?
|
| International Cooperation | 1 | 2009 | 52 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2010 | 181 | 0.080 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2009 | 3 | 0.080 |
Why?
|
| Public Policy | 1 | 2009 | 36 | 0.080 |
Why?
|
| Trehalose | 1 | 2009 | 5 | 0.080 |
Why?
|
| Autophagy | 1 | 2011 | 140 | 0.080 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 5 | 2009 | 84 | 0.080 |
Why?
|
| Chemistry, Physical | 2 | 2006 | 50 | 0.080 |
Why?
|
| Culture Media | 3 | 2018 | 96 | 0.080 |
Why?
|
| Chemical Phenomena | 2 | 2006 | 56 | 0.080 |
Why?
|
| X-Ray Microtomography | 2 | 2019 | 22 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2010 | 132 | 0.080 |
Why?
|
| Bivalvia | 2 | 2008 | 28 | 0.070 |
Why?
|
| Lasers, Solid-State | 1 | 2009 | 12 | 0.070 |
Why?
|
| City Planning | 1 | 2008 | 2 | 0.070 |
Why?
|
| Propylene Glycols | 1 | 2008 | 6 | 0.070 |
Why?
|
| Stearic Acids | 1 | 2008 | 7 | 0.070 |
Why?
|
| Curcumin | 1 | 2010 | 118 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 81 | 0.070 |
Why?
|
| Dental Scaling | 2 | 2018 | 3 | 0.070 |
Why?
|
| Flavonoids | 2 | 2010 | 100 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 458 | 0.070 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2008 | 4 | 0.070 |
Why?
|
| Imidazoles | 2 | 2009 | 142 | 0.070 |
Why?
|
| Aurovertins | 1 | 2008 | 1 | 0.070 |
Why?
|
| Pyrrolidinones | 2 | 2010 | 11 | 0.070 |
Why?
|
| Pyridines | 2 | 2009 | 139 | 0.070 |
Why?
|
| Metarhizium | 1 | 2008 | 4 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2019 | 158 | 0.070 |
Why?
|
| Methane | 1 | 2007 | 12 | 0.070 |
Why?
|
| Prodigiosin | 1 | 2007 | 4 | 0.070 |
Why?
|
| Carboxylic Acids | 1 | 2007 | 15 | 0.070 |
Why?
|
| Photosensitizing Agents | 1 | 2008 | 56 | 0.070 |
Why?
|
| Odontogenesis | 1 | 2007 | 4 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2006 | 506 | 0.070 |
Why?
|
| Porphyrins | 1 | 2008 | 57 | 0.070 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2007 | 26 | 0.070 |
Why?
|
| Sialoglycoproteins | 2 | 2007 | 14 | 0.070 |
Why?
|
| Anthraquinones | 1 | 2007 | 9 | 0.070 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 34 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2007 | 28 | 0.070 |
Why?
|
| Urochordata | 1 | 2007 | 5 | 0.060 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2007 | 6 | 0.060 |
Why?
|
| beta-Glucans | 1 | 2007 | 11 | 0.060 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2007 | 97 | 0.060 |
Why?
|
| Cell Adhesion | 3 | 2016 | 238 | 0.060 |
Why?
|
| Prevalence | 3 | 2020 | 1612 | 0.060 |
Why?
|
| Aspergillus | 1 | 2006 | 14 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2021 | 1035 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 1009 | 0.060 |
Why?
|
| Connexin 43 | 1 | 2006 | 41 | 0.060 |
Why?
|
| Pyrones | 1 | 2006 | 11 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2007 | 110 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 3 | 2013 | 290 | 0.060 |
Why?
|
| Lysine | 1 | 2006 | 119 | 0.060 |
Why?
|
| Proteus Infections | 1 | 2025 | 1 | 0.060 |
Why?
|
| Densitometry | 1 | 2005 | 16 | 0.060 |
Why?
|
| Chemotactic Factors | 1 | 2005 | 8 | 0.060 |
Why?
|
| Antiporters | 1 | 2025 | 14 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2005 | 25 | 0.060 |
Why?
|
| Sex Factors | 2 | 2020 | 1028 | 0.060 |
Why?
|
| Petrosia | 1 | 2005 | 1 | 0.060 |
Why?
|
| Osteoprotegerin | 2 | 2002 | 16 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2002 | 37 | 0.060 |
Why?
|
| Acetylene | 1 | 2005 | 5 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2006 | 140 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2006 | 126 | 0.060 |
Why?
|
| Alcohols | 1 | 2005 | 14 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2007 | 199 | 0.060 |
Why?
|
| Urinary Tract Infections | 1 | 2025 | 44 | 0.060 |
Why?
|
| Rotifera | 1 | 2005 | 13 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2007 | 159 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 256 | 0.060 |
Why?
|
| Receptors, Lipoxin | 1 | 2005 | 1 | 0.060 |
Why?
|
| Purine Nucleosides | 1 | 2005 | 14 | 0.060 |
Why?
|
| Tosyl Compounds | 1 | 2005 | 4 | 0.060 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2005 | 3 | 0.060 |
Why?
|
| Fungi | 1 | 2006 | 106 | 0.060 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2005 | 7 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2021 | 735 | 0.060 |
Why?
|
| Biological Transport | 1 | 2025 | 204 | 0.060 |
Why?
|
| Cell Line, Tumor | 5 | 2015 | 2676 | 0.060 |
Why?
|
| Lipids | 1 | 2007 | 256 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2018 | 456 | 0.050 |
Why?
|
| Disease Progression | 2 | 2018 | 667 | 0.050 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2024 | 5 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 652 | 0.050 |
Why?
|
| Mandible | 1 | 2024 | 12 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2004 | 78 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2024 | 47 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 140 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2004 | 28 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2023 | 49 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2019 | 760 | 0.050 |
Why?
|
| Bone Marrow Cells | 2 | 2017 | 79 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 70 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 45 | 0.050 |
Why?
|
| Integrins | 1 | 2023 | 54 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 80 | 0.050 |
Why?
|
| Pancreas | 1 | 2023 | 45 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2016 | 249 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2017 | 465 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 224 | 0.050 |
Why?
|
| Dentin, Secondary | 1 | 2003 | 1 | 0.050 |
Why?
|
| Calcium Hydroxide | 1 | 2003 | 2 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 968 | 0.050 |
Why?
|
| Linoleic Acid | 1 | 2003 | 9 | 0.050 |
Why?
|
| Histone Deacetylase 2 | 1 | 2022 | 5 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2022 | 35 | 0.050 |
Why?
|
| Histone Deacetylase 1 | 1 | 2022 | 16 | 0.050 |
Why?
|
| Lactobacillus | 1 | 2003 | 22 | 0.050 |
Why?
|
| Equipment Design | 2 | 2014 | 145 | 0.050 |
Why?
|
| Comorbidity | 2 | 2018 | 737 | 0.050 |
Why?
|
| O Antigens | 1 | 2002 | 7 | 0.050 |
Why?
|
| Lipid A | 1 | 2002 | 8 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2022 | 33 | 0.050 |
Why?
|
| Incidence | 2 | 2018 | 1078 | 0.050 |
Why?
|
| Bacteroides | 1 | 2002 | 10 | 0.050 |
Why?
|
| Mycolic Acids | 1 | 2002 | 2 | 0.050 |
Why?
|
| Pyrroles | 1 | 2003 | 72 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2002 | 24 | 0.050 |
Why?
|
| Mastication | 1 | 2022 | 24 | 0.050 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2002 | 51 | 0.050 |
Why?
|
| Mycobacterium | 1 | 2002 | 16 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 150 | 0.050 |
Why?
|
| Adolescent | 3 | 2012 | 6081 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2013 | 374 | 0.050 |
Why?
|
| Stereoisomerism | 3 | 2008 | 169 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2002 | 64 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 145 | 0.050 |
Why?
|
| Lipopolysaccharides | 3 | 2010 | 239 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2013 | 259 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 247 | 0.040 |
Why?
|
| Peptides | 1 | 2005 | 372 | 0.040 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2013 | 38 | 0.040 |
Why?
|
| Fermentation | 3 | 2007 | 39 | 0.040 |
Why?
|
| Sewage | 2 | 2014 | 27 | 0.040 |
Why?
|
| Histones | 1 | 2022 | 197 | 0.040 |
Why?
|
| Indoles | 1 | 2003 | 187 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2016 | 518 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2002 | 575 | 0.040 |
Why?
|
| Young Adult | 4 | 2013 | 5080 | 0.040 |
Why?
|
| Oroantral Fistula | 1 | 2020 | 1 | 0.040 |
Why?
|
| Maxillary Sinus | 1 | 2020 | 4 | 0.040 |
Why?
|
| Tooth Extraction | 1 | 2020 | 5 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2020 | 3 | 0.040 |
Why?
|
| Pedigree | 1 | 2020 | 94 | 0.040 |
Why?
|
| Osteoclasts | 1 | 2020 | 28 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 83 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 110 | 0.040 |
Why?
|
| CD4-CD8 Ratio | 1 | 2019 | 29 | 0.040 |
Why?
|
| Leukemia P388 | 2 | 2010 | 2 | 0.040 |
Why?
|
| Marine Biology | 2 | 2010 | 9 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2019 | 201 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 104 | 0.040 |
Why?
|
| DNA | 1 | 2002 | 592 | 0.040 |
Why?
|
| Chondrogenesis | 1 | 2018 | 4 | 0.040 |
Why?
|
| Cell Aggregation | 1 | 2018 | 17 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2018 | 14 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 245 | 0.040 |
Why?
|
| Root Planing | 1 | 2018 | 2 | 0.040 |
Why?
|
| Drug Interactions | 2 | 2010 | 150 | 0.040 |
Why?
|
| Periodontal Attachment Loss | 1 | 2018 | 9 | 0.040 |
Why?
|
| Periodontal Pocket | 1 | 2018 | 6 | 0.040 |
Why?
|
| Secondary Prevention | 2 | 2012 | 48 | 0.040 |
Why?
|
| rho-Associated Kinases | 1 | 2018 | 36 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 32 | 0.040 |
Why?
|
| HMGB1 Protein | 1 | 2018 | 30 | 0.040 |
Why?
|
| Smoking | 2 | 2018 | 1024 | 0.040 |
Why?
|
| Postprandial Period | 1 | 2018 | 13 | 0.040 |
Why?
|
| Gastritis, Atrophic | 1 | 2018 | 13 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2018 | 6 | 0.040 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2018 | 2 | 0.030 |
Why?
|
| Collagenases | 1 | 2018 | 29 | 0.030 |
Why?
|
| Eosinophils | 1 | 2018 | 24 | 0.030 |
Why?
|
| Periodontal Index | 1 | 2018 | 10 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2009 | 99 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 55 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2018 | 20 | 0.030 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 61 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2018 | 37 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 300 | 0.030 |
Why?
|
| Food Coloring Agents | 1 | 2017 | 1 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 2017 | 9 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2018 | 192 | 0.030 |
Why?
|
| Benzaldehydes | 1 | 2017 | 8 | 0.030 |
Why?
|
| Monocytes | 1 | 2019 | 277 | 0.030 |
Why?
|
| Immunoassay | 1 | 2018 | 74 | 0.030 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 8 | 0.030 |
Why?
|
| Amplified Fragment Length Polymorphism Analysis | 1 | 2017 | 1 | 0.030 |
Why?
|
| Molecular Weight | 2 | 2011 | 168 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 2017 | 23 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 51 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 70 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2017 | 30 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 98 | 0.030 |
Why?
|
| Color | 1 | 2017 | 38 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 173 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2017 | 74 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2018 | 94 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 861 | 0.030 |
Why?
|
| beta-Cyclodextrins | 1 | 2016 | 35 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 1067 | 0.030 |
Why?
|
| Cytochalasin D | 1 | 2016 | 4 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2018 | 389 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2016 | 33 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2016 | 26 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 734 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 587 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 31 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 587 | 0.030 |
Why?
|
| Gingivitis | 1 | 2015 | 9 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 296 | 0.030 |
Why?
|
| Cell Separation | 1 | 2016 | 94 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2007 | 12 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 247 | 0.030 |
Why?
|
| Dioxoles | 1 | 2015 | 8 | 0.030 |
Why?
|
| Caspase 7 | 1 | 2015 | 18 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 712 | 0.030 |
Why?
|
| Furcation Defects | 1 | 2014 | 1 | 0.030 |
Why?
|
| Tooth Ankylosis | 1 | 2014 | 1 | 0.030 |
Why?
|
| Tooth Root | 1 | 2014 | 3 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2014 | 23 | 0.030 |
Why?
|
| Giant Cells | 1 | 2014 | 15 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2007 | 403 | 0.030 |
Why?
|
| Femur | 1 | 2015 | 47 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2015 | 57 | 0.030 |
Why?
|
| Pasteurellaceae Infections | 1 | 2014 | 2 | 0.030 |
Why?
|
| Systems Theory | 1 | 2014 | 4 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 411 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 170 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 386 | 0.030 |
Why?
|
| Thailand | 1 | 2014 | 51 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 227 | 0.030 |
Why?
|
| Ecology | 1 | 2014 | 33 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2014 | 168 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2016 | 321 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2016 | 311 | 0.030 |
Why?
|
| Agriculture | 1 | 2014 | 66 | 0.030 |
Why?
|
| Demography | 1 | 2014 | 195 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 181 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 19 | 0.030 |
Why?
|
| Propensity Score | 1 | 2013 | 59 | 0.030 |
Why?
|
| Receptors, OX40 | 1 | 2013 | 7 | 0.030 |
Why?
|
| Mesentery | 1 | 2013 | 9 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2014 | 229 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2013 | 25 | 0.020 |
Why?
|
| Candida albicans | 2 | 2007 | 176 | 0.020 |
Why?
|
| Peyer's Patches | 1 | 2013 | 16 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2013 | 52 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2013 | 26 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 189 | 0.020 |
Why?
|
| Mucins | 1 | 2013 | 73 | 0.020 |
Why?
|
| Ecosystem | 1 | 2014 | 175 | 0.020 |
Why?
|
| Postoperative Hemorrhage | 1 | 2012 | 15 | 0.020 |
Why?
|
| Intestinal Perforation | 1 | 2012 | 11 | 0.020 |
Why?
|
| Eggs | 1 | 2012 | 14 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 95 | 0.020 |
Why?
|
| Gefarnate | 1 | 2012 | 1 | 0.020 |
Why?
|
| Esophagitis | 1 | 2012 | 7 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2013 | 171 | 0.020 |
Why?
|
| Cell Division | 1 | 2013 | 311 | 0.020 |
Why?
|
| Sleep Deprivation | 1 | 2012 | 28 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2012 | 57 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2012 | 55 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2012 | 18 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2012 | 53 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2012 | 51 | 0.020 |
Why?
|
| Quality of Life | 1 | 2017 | 616 | 0.020 |
Why?
|
| Teaching Materials | 1 | 2012 | 10 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2012 | 19 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2012 | 43 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 368 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2011 | 37 | 0.020 |
Why?
|
| Vitamin K 2 | 1 | 2011 | 1 | 0.020 |
Why?
|
| Fumonisins | 1 | 2010 | 1 | 0.020 |
Why?
|
| CA-19-9 Antigen | 1 | 2010 | 1 | 0.020 |
Why?
|
| Phagosomes | 1 | 2011 | 33 | 0.020 |
Why?
|
| Pancreatectomy | 1 | 2010 | 10 | 0.020 |
Why?
|
| Micrococcus luteus | 1 | 2010 | 4 | 0.020 |
Why?
|
| Depression | 1 | 2018 | 863 | 0.020 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2010 | 6 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2012 | 156 | 0.020 |
Why?
|
| Fatty Alcohols | 1 | 2010 | 9 | 0.020 |
Why?
|
| Consensus | 1 | 2010 | 48 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 388 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 155 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 229 | 0.020 |
Why?
|
| Sirolimus | 1 | 2011 | 70 | 0.020 |
Why?
|
| Endodontics | 1 | 2010 | 1 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2010 | 15 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2010 | 3 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2010 | 13 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 10 | 0.020 |
Why?
|
| Anthracenes | 1 | 2010 | 15 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2010 | 83 | 0.020 |
Why?
|
| Anxiety | 1 | 2018 | 874 | 0.020 |
Why?
|
| Lysosomes | 1 | 2011 | 86 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 41 | 0.020 |
Why?
|
| Heparin | 1 | 2010 | 40 | 0.020 |
Why?
|
| Colonic Polyps | 1 | 2011 | 71 | 0.020 |
Why?
|
| Quinazolines | 1 | 2010 | 38 | 0.020 |
Why?
|
| Stomach | 1 | 2010 | 50 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2009 | 27 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 107 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 84 | 0.020 |
Why?
|
| Tyrosine | 1 | 2010 | 120 | 0.020 |
Why?
|
| Obesity | 1 | 2018 | 1151 | 0.020 |
Why?
|
| Necrosis | 1 | 2009 | 54 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2009 | 64 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 90 | 0.020 |
Why?
|
| Artemisia | 1 | 2009 | 4 | 0.020 |
Why?
|
| Cattle | 1 | 2011 | 498 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 100 | 0.020 |
Why?
|
| Economics | 1 | 2009 | 7 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 206 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 61 | 0.020 |
Why?
|
| Acylation | 1 | 2008 | 11 | 0.020 |
Why?
|
| Propanolamines | 1 | 2008 | 13 | 0.020 |
Why?
|
| Mouth Neoplasms | 1 | 2009 | 60 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 638 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 54 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 278 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2012 | 469 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 159 | 0.020 |
Why?
|
| Photochemistry | 1 | 2008 | 57 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 925 | 0.020 |
Why?
|
| Fossil Fuels | 1 | 2007 | 2 | 0.020 |
Why?
|
| Animals, Domestic | 1 | 2007 | 11 | 0.020 |
Why?
|
| Nervous System | 1 | 2008 | 32 | 0.020 |
Why?
|
| Electricity | 1 | 2007 | 12 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2008 | 98 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 64 | 0.020 |
Why?
|
| Gases | 1 | 2007 | 25 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2008 | 47 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 141 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2007 | 36 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 186 | 0.020 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2007 | 9 | 0.020 |
Why?
|
| Superoxides | 1 | 2007 | 57 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2008 | 108 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 86 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2007 | 18 | 0.020 |
Why?
|
| Micromonospora | 1 | 2007 | 2 | 0.020 |
Why?
|
| Cisplatin | 1 | 2008 | 98 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2007 | 114 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2008 | 114 | 0.020 |
Why?
|
| Splints | 1 | 2007 | 2 | 0.020 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2007 | 19 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 532 | 0.020 |
Why?
|
| Neuromuscular Agents | 1 | 2007 | 5 | 0.020 |
Why?
|
| Vibrio | 1 | 2007 | 19 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2007 | 78 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1154 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2007 | 124 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 155 | 0.020 |
Why?
|
| Food | 1 | 2007 | 103 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2007 | 61 | 0.020 |
Why?
|
| Analgesics | 1 | 2007 | 55 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2007 | 168 | 0.020 |
Why?
|
| Diet | 1 | 2012 | 826 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2007 | 204 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2012 | 661 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 220 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2009 | 403 | 0.010 |
Why?
|
| Polyamines | 1 | 2005 | 32 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 749 | 0.010 |
Why?
|
| Plant Leaves | 1 | 2005 | 136 | 0.010 |
Why?
|
| Ethanol | 1 | 2007 | 224 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2004 | 47 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2005 | 182 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 508 | 0.010 |
Why?
|
| Sulfuric Acid Esters | 1 | 2003 | 5 | 0.010 |
Why?
|
| Flowers | 1 | 2003 | 20 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 34 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 355 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2003 | 31 | 0.010 |
Why?
|
| Silver Nitrate | 1 | 2003 | 5 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 2003 | 13 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2004 | 112 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2003 | 51 | 0.010 |
Why?
|
| Isomerism | 1 | 2003 | 64 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2004 | 518 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 54 | 0.010 |
Why?
|
| Carbohydrate Conformation | 1 | 2002 | 15 | 0.010 |
Why?
|
| Serine | 1 | 2003 | 79 | 0.010 |
Why?
|
| Magnesium | 1 | 2003 | 94 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 102 | 0.010 |
Why?
|
| Acrylamides | 1 | 2002 | 14 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 134 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 196 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2002 | 71 | 0.010 |
Why?
|
| Ions | 1 | 2002 | 71 | 0.010 |
Why?
|
| Cnidarian Venoms | 1 | 2002 | 24 | 0.010 |
Why?
|
| Virulence | 1 | 2002 | 246 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 876 | 0.010 |
Why?
|
| Glucose | 1 | 2003 | 244 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2002 | 109 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 983 | 0.010 |
Why?
|
| United States | 1 | 2011 | 5205 | 0.010 |
Why?
|
| Neoplasms | 1 | 2009 | 1377 | 0.010 |
Why?
|